Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cureus ; 15(10): e46785, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37954729

RESUMO

INTRODUCTION:  Sunscreen marketing to specific demographics is largely unregulated. Marketing specifically targeting pediatric populations has the potential to drive consumer behavior. The American Academy of Pediatrics (AAP) and American Academy of Dermatology (AAD) provide recommendations for sunscreen use in children over the age of six months. This study sought to determine if sunscreen products marketed toward pediatric populations align with healthcare guidelines. MATERIALS AND METHODS: Sunscreens available in major retail outlets in the Philadelphia area were cataloged and reviewed for marketing targeting specific demographics such as "baby", "babies", "children", "kids", "sports", and "active". The products were reviewed for sun protection factor (SPF), broad-spectrum ultraviolet (UV) protection, water resistance, active UV filters, and application method.  Results: Of 410 sunscreens cataloged, 27 were marketed towards "baby" or "babies", 44 towards "children" or "kids", and 71 towards "sports" or "active". All of the sunscreen products reviewed targeting the pediatric population offered water resistance for up to 80 minutes and broad-spectrum UV coverage. Sunscreens targeting "baby" or "babies" aligned most closely with AAP guidelines for sunscreen use in pediatric populations, with 92.6% offering an SPF between 15 to 50 and no products including oxybenzone as a UV filter. However, sunscreens targeting "children", "kids", "sports", and "active" bore a close resemblance to the overall sunscreen profile for all demographics but with a higher percentage of products containing oxybenzone. Oxybenzone was found in 11.4% of "children" and "kids" products and 16.9% of "sports" and "active" sunscreen products, compared to 7.6% of all sunscreen products available, and was also found in most sunscreen products with an SPF of 70 or higher. CONCLUSION:  Sunscreen products marketed towards "baby" and "babies" tend to align closely with guidelines for sunscreen use in the pediatric population for children over six months of age; however, those with brand marketing towards "children", "kids", "sports", and "active" do not. Limiting recommendations for a sunscreen product with an SPF of 30 to 50 targeting this demographic, however, sufficiently meets guidelines set forth by the AAP and AAD.

2.
Cureus ; 15(8): e42794, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-37664385

RESUMO

INTRODUCTION: The impact of ultraviolet (UV) light on the skin is well-established to have both immediate and delayed effects with increasing awareness of the impact of visible light (VL) on the skin with regard to photoaging and dyspigmentation. The effects of VL disproportionately impact the skin of color with regard to discoloration of the skin leading to guidelines for photoprotection that include the use of iron oxides in sunscreen products that impart a tint. METHODS: Commercially available sunscreen products found in the suncare and sun protection displays at local stores, pharmacies, and grocery stores were cataloged, and ingredients were reviewed for the presence of iron oxides. RESULTS: Of the 410 commercially available sunscreen products cataloged, 1.7% of facial sunscreen products available offered iron oxides, and 0.5% of non-lip products offered shade matching. CONCLUSION: With only 1.7% of commercially available facial sunscreen products offering iron oxides in addition to traditional broad-spectrum UV protection, there is a clear gap in the market for iron oxide-containing sunscreen products to meet the photoprotection needs for the skin of color.

3.
Cureus ; 15(8): e44137, 2023 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-37753032

RESUMO

INTRODUCTION:  Excess ultraviolet (UV) radiation exposure during childhood poses a particular long-term risk of developing skin cancer later in life however recent studies have called attention to the absorption of chemical sunscreen ingredients into the bloodstream with unclear significance. This has led to recommendations to consider sun protection in the form of clothing to reduce the need for sunscreen products. METHODS:  Ten brands of routine summer clothing not labeled as sun protective from five distributors marketed for children were identified with varying price ranges. Summer clothing items consisting of T-shirts and tops were evaluated for fiber composition, cost, and UPF testing was performed to determine UVA and UVB transmittance.  Results: Around 88.2% of blended textile compositions compared to 60% of 100% cotton textiles offered adequate UV protection with an Ultraviolet Protection Factor (UPF) greater than 15. 58% of blended fabrics compared to 50% of cotton textiles offered a UPF greater than 30. There was no correlation between brand and cost with UPF values.  Conclusions: In the absence of regulations for testing and labeling of all children's garments for UV protection, guidelines for the pediatric population for choosing clothing for the summer should reflect the information available to consumers that is easy to understand and more likely to result in higher UPF values. Based on fiber composition, blended textiles are more likely to have adequate UV protection compared to 100% cotton or 100% polyester.

4.
Cureus ; 15(7): e42256, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-37605709

RESUMO

Background Ultraviolet (UV) radiation has potentially harmful effects on the skin. Sunscreen products have historically focused on blocking UV-B radiation to prevent sunburns while efforts to block UV-A radiation have been lacking. UV protective clothing, rated by ultraviolet protection factor (UPF) values, has gained popularity as an alternative form of UV protection, offering a physical barrier against UV rays. However, concerns arise regarding the disclosure and sustainability of UV-protective textiles, as companies often do not disclose the methods used to achieve UV protection. The addition of chemical sunscreen additives to textiles raises questions about their potential release during laundering and their impact on sustained UV protection and environmental health. Further research is needed to understand the risks and benefits of these practices. Methods Seven garments from commercially available sun-protective brand names claiming UV protection were tested for UPF values. The garments were washed separately using cold water in commercially available detergent in cold water followed by drying on a low setting. UPF measurements were obtained at baseline and at intervals of 10 wash cycles until 50 wash cycles were completed. Results Two brands (Brands A and D) experienced a significant decrease in UPF value (70% to 78%) by the completion of 50 washes. Brand A disclosed the use of a nano-zinc additive in their garments while Brand D did not disclose the means of achieving UV protection. In comparison, five brands (Brands B, C, E, F, G) maintained relatively stable UPF values throughout the 50 washes. The comparison between Brand A and Brand G, who disclosed their UV protection methods, showed that Brand A gradually decreased in UPF value throughout the washes while Brand G remained stable. Conclusion The findings suggest that textile compositions with UV finishes may lose their UPF effectiveness during laundering by loss of the finish used over time or the textile integrity could be affected. This raises questions about the necessity of adding these UV finishes if there are fabrics that can maintain their UPF values without them.

5.
Dermatol Surg ; 46(3): 319-326, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31356441

RESUMO

BACKGROUND: The treatment of nonmelanoma skin cancer (NMSC) in the elderly population is a source of significant debate. Mohs micrographic surgery (MMS) is a highly effective treatment option yet not every patient with a cutaneous malignancy that meets appropriate use criteria (AUC) should be treated with surgery. OBJECTIVE: The purpose of this study was to use the Karnofsky Performance Status (KPS) scale to categorize the functional status of patients aged 75 years and older who required treatment of NMSC. The authors wanted to see whether functionality played a role on the treatment selection. METHODS: Patients aged 75 years and older presenting for biopsy of a suspected NMSC that met AUC for MMS were included in the study. Trained medical assistants used the KPS scale to assess patient functionality. Treatment modality was recorded once the biopsy confirmed the NMSC. RESULTS: A cohort of 203 subjects met inclusion criteria for the study. There was a statistically significant difference in utilization of surgical treatments between high and low functionality patients (p = .03). CONCLUSION: Dermatologists consider patient functionality when selecting a treatment for NMSC and use less invasive modalities for patients with poor functional status, even when the tumor meets AUC.


Assuntos
Avaliação de Estado de Karnofsky , Neoplasias Cutâneas/terapia , Idoso , Idoso de 80 Anos ou mais , Biópsia , Carcinoma Basocelular/terapia , Carcinoma de Células Escamosas/terapia , Feminino , Avaliação Geriátrica , Humanos , Masculino , Cirurgia de Mohs , Seleção de Pacientes , Estudos Prospectivos , Estados Unidos
6.
J Hand Surg Am ; 37(1): 171-8, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22196297

RESUMO

Skin cancers represent the most common primary malignancies of the hand. They typically present as painless lesions on areas of high sun exposure, such as the dorsum of the hand and upper extremity. The most common malignancy is squamous cell carcinoma, followed by basal cell carcinoma and melanoma. The key to successful treatment is early and accurate diagnosis and treatment. Unlike open biopsies, which are indicated for deep soft tissue and bone lesions, biopsies for skin cancer can be performed under local anesthesia in the office setting in the form of shave or punch biopsies. A number of nonsurgical treatment options are available for treatment. However, when surgical excision is indicated, appropriate margin resections are dictated by the grade and stage of the malignancy.


Assuntos
Mãos/patologia , Neoplasias Cutâneas/epidemiologia , Neoplasias Cutâneas/patologia , Extremidade Superior/patologia , Carcinoma Basocelular/diagnóstico , Carcinoma Basocelular/epidemiologia , Carcinoma Basocelular/terapia , Carcinoma de Célula de Merkel/diagnóstico , Carcinoma de Célula de Merkel/epidemiologia , Carcinoma de Célula de Merkel/terapia , Detecção Precoce de Câncer , Educação Médica Continuada , Feminino , Humanos , Incidência , Masculino , Melanoma/diagnóstico , Melanoma/epidemiologia , Melanoma/terapia , Invasividade Neoplásica/patologia , Estadiamento de Neoplasias , Prognóstico , Medição de Risco , Neoplasias Cutâneas/diagnóstico , Neoplasias Cutâneas/terapia , Resultado do Tratamento
9.
Cutis ; 75(3): 167-8, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15839360

RESUMO

Traditionally, systemic 5-fluorouracil has been associated with a reaction that produces inflammation of preexisting and subclinical actinic keratoses (AKs). We report a case of an inflammatory reaction occurring in AKs secondary to the use of doxorubicin. The cutaneous reaction was successfully managed with the application of high-potency topical steroids over the body and with pain management. When the doxorubicin was discontinued and another agent (paclitaxel) was instituted, the cutaneous reaction gradually diminished.


Assuntos
Antineoplásicos/efeitos adversos , Doxorrubicina/efeitos adversos , Ceratose/etiologia , Raios Ultravioleta/efeitos adversos , Administração Tópica , Corticosteroides/administração & dosagem , Neoplasias da Mama/tratamento farmacológico , Feminino , Humanos , Ceratose/tratamento farmacológico , Pessoa de Meia-Idade
11.
Cutis ; 73(1): 39-43, 2004 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-14964630

RESUMO

We report the case of a 6-week-old girl who presented with a pedunculated embryonal rhabdomyosarcoma arising in a giant congenital melanocytic nevus (GCMN) on her lower back. There was no associated leptomeningeal involvement. The patient underwent surgical resection of the rhabdomyosarcoma at age 2 months, with subsequent chemotherapy consisting of actinomycin D and vincristine. No recurrences or metastases of tumor have been noted at 5 months of age.


Assuntos
Nevo Pigmentado/patologia , Lesões Pré-Cancerosas/patologia , Rabdomiossarcoma/patologia , Neoplasias Cutâneas/patologia , Biópsia por Agulha , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Lactente , Nevo Pigmentado/cirurgia , Lesões Pré-Cancerosas/cirurgia , Rabdomiossarcoma/cirurgia , Medição de Risco , Neoplasias Cutâneas/cirurgia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...